FR3077823B1 - Procede de preparation d'un lysat plaquettaire irradie - Google Patents

Procede de preparation d'un lysat plaquettaire irradie Download PDF

Info

Publication number
FR3077823B1
FR3077823B1 FR1851307A FR1851307A FR3077823B1 FR 3077823 B1 FR3077823 B1 FR 3077823B1 FR 1851307 A FR1851307 A FR 1851307A FR 1851307 A FR1851307 A FR 1851307A FR 3077823 B1 FR3077823 B1 FR 3077823B1
Authority
FR
France
Prior art keywords
factor
platelet lysate
starting
irradated
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1851307A
Other languages
English (en)
Other versions
FR3077823A1 (fr
Inventor
Bruno Delorme
Sabrina Viau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maco Pharma SAS
Original Assignee
Maco Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maco Pharma SAS filed Critical Maco Pharma SAS
Priority to FR1851307A priority Critical patent/FR3077823B1/fr
Priority to EP19705334.1A priority patent/EP3752207A1/fr
Priority to PCT/EP2019/053472 priority patent/WO2019158540A1/fr
Priority to US16/969,600 priority patent/US20210032590A1/en
Publication of FR3077823A1 publication Critical patent/FR3077823A1/fr
Application granted granted Critical
Publication of FR3077823B1 publication Critical patent/FR3077823B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
    • C12N2529/10—Stimulation by light

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procédé de préparation d'un lysat plaquettaire irradié comprenant les étapes suivantes : - la fourniture d'un lysat plaquettaire de départ comprenant d'une part des facteurs plaquettaires incluant des facteurs de croissance et d'autre part des protéines plasmatiques incluant des facteurs de coagulation et des protéines autres que les facteurs de coagulation, - la double irradiation dudit lysat plaquettaire de départ, par un rayonnement UVC et par un rayonnement ionisant, ladite double irradiation par rayonnement UVC et par rayonnement ionisant étant agencée pour conserver au moins 75% de la concentration en protéines totales dudit lysat plaquettaire de départ tout en réduisant d'au moins 40% la concentration en au moins un desdits facteurs de coagulation incluant le fibrinogène, le facteur II, le facteur VII, le facteur IX, le facteur X et le facteur XI du lysat plaquettaire de départ.
FR1851307A 2018-02-15 2018-02-15 Procede de preparation d'un lysat plaquettaire irradie Active FR3077823B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1851307A FR3077823B1 (fr) 2018-02-15 2018-02-15 Procede de preparation d'un lysat plaquettaire irradie
EP19705334.1A EP3752207A1 (fr) 2018-02-15 2019-02-12 Procédé de préparation d'un lysat plaquettaire irradié
PCT/EP2019/053472 WO2019158540A1 (fr) 2018-02-15 2019-02-12 Procédé de préparation d'un lysat plaquettaire irradié
US16/969,600 US20210032590A1 (en) 2018-02-15 2019-02-12 Method for preparing an irradiated platelet lysate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1851307 2018-02-15
FR1851307A FR3077823B1 (fr) 2018-02-15 2018-02-15 Procede de preparation d'un lysat plaquettaire irradie

Publications (2)

Publication Number Publication Date
FR3077823A1 FR3077823A1 (fr) 2019-08-16
FR3077823B1 true FR3077823B1 (fr) 2022-01-14

Family

ID=62683308

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1851307A Active FR3077823B1 (fr) 2018-02-15 2018-02-15 Procede de preparation d'un lysat plaquettaire irradie

Country Status (4)

Country Link
US (1) US20210032590A1 (fr)
EP (1) EP3752207A1 (fr)
FR (1) FR3077823B1 (fr)
WO (1) WO2019158540A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2069479A1 (fr) 2006-09-18 2009-06-17 Medizinische Universität Graz Lysat de plaquettes exempt de plasma destiné à être utilisé comme supplément dans des cultures cellulaires et pour la préparation de produits thérapeutiques cellulaires
EP2334785B2 (fr) * 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Compositions à contenu plaquettaire
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
EP2723354B3 (fr) 2011-06-27 2021-03-24 Emory University Compositions, utilisations et préparation de lysats de plaquettes
ITRM20110500A1 (it) * 2011-09-23 2013-03-24 Futura Stem Cells Sa Lisato piastrinico, usi di esso e metodo per la sua preparazione
EP2733200A1 (fr) * 2012-11-15 2014-05-21 Biorigen International SA Suppléments de culture cellulaire
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
TWI744300B (zh) 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途

Also Published As

Publication number Publication date
EP3752207A1 (fr) 2020-12-23
FR3077823A1 (fr) 2019-08-16
WO2019158540A1 (fr) 2019-08-22
US20210032590A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
Lefkovits Induction of antibody‐forming cell clones in microcultures
PT633721E (pt) Descontaminacao de plaquetas com 8-metoxipsoraleno
Castro et al. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion‐associated graft‐versus‐host disease
Terpstra et al. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates
FR3036707B1 (fr) Procede de sterilisation d'un lysat plaquettaire
BR112021019070A2 (pt) Ligantes de pseudoquinase tyk2
Sheth et al. Evaluation of new technique of sterilization using biological indicator
FR3077823B1 (fr) Procede de preparation d'un lysat plaquettaire irradie
BR0011430A (pt) Estocagem e manutenção aperfeiçoadas de produtos de sangue incluindo células vermelhas de sangue e plaquetas
BR112021025116A2 (pt) Células linfocíticas ativadas e métodos de uso das mesmas para tratar câncer e condições infecciosas
BR112022008821A2 (pt) Ligantes de pseudoquinase tyk2
ES2062809T3 (es) Proteinas bacterianas del estres.
Barro et al. A double‐virally‐inactivated (intercept–solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells
BR112021022380A2 (pt) Inibidores de jak
Nyman et al. Proteomics to study macrophage response to viral infection
FR3077824B1 (fr) Procede de preparation d'un lysat plaquettaire irradie
BR112019008359A2 (pt) método para tratamento da doença de alzheimer, e, composição farmacêutica.
Aoki et al. Medullasin enhances human natural killer cell activity.
LoGRIPPO et al. Procedure for bone sterilization with beta-propiolactone
BR112022002868A2 (pt) Indicador biológico para determinar a eficácia de um processo de esterilização por vapor ou calor e seu método de uso
Werz et al. Strategies to avoid virus transmissions by biopharmaceutic products
Salle et al. An improved method for the evaluation of germicidal substances
BR112022011051A2 (pt) Métodos para inativação viral através de detergentes ambientalmente compatíveis
Ulrich et al. A simple micro tissue culture method for the determination of lymphocyte cytotoxicity in vitro
Rossman et al. Blocking of interferon action by a component of normal serum

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190816

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7